Deep expertise in biotechnology, to effectively secure and protect IP
With a PhD in immunology and over a decade of research in the field of life sciences, Dr. Bryant Boulianne offers a unique depth of expertise in biotechnology to client activities. Bryant’s practice focusses on the preparation and acquisition of patent protection. He aids in the drafting and prosecution of biotechnology and pharmaceutical patent applications before the Canadian Intellectual Property Office, the United States Patent and Trademark Office and abroad.
IP perspective informed by scientific insight and hands on experience
As an immunologist Bryant offers authority, insight and understanding into important IP classes including molecular biology, biologics and cancer therapy. His client activities involve pharmaceutical and biotechnology companies, universities and research institutions.
Bryant has written seven first-author publications in international scientific journals. Though his specialization is as an immunologist, his work has also dealt with parasitology, protozoology, evolution, botany and cancer.
Qualifications
- News
- In the Media
Publications
- "Transcribing Malignancy: transcription-associated genomic instability in cancer" (co-author: Feldhahn, N), Oncogene, February 22, 2018
- "Lineage-Specific Genes Are Prominent DNA Damage Hotspots during Leukemic Transformation of B Cell Precursors" (co-authors: Robinson ME, Philippa MC, Castellano L, Blighe K, Thomas J, Reid A, Muschen M, Apperley JF, Stebbing J, Feldhahn N), Cell Reports, February 14, 2017
- "AID and caspase 8 shape the germinal center response through apoptosis" (co-authors: Rojas OL, Haddad D, Zaheen A, Kapelnikov A, Nguyen T, Li C, Hakem R, Gommerman JL, Martin A), The Journal of Immunology, December 15, 2013
- "AID-expressing germinal center B cells cluster normally within lymph node follicles in the absence of FDC-M1+CD35+ follicular dendritic cells but dissipate prematurely" (co-authors: Le MX, Ward LA, Meng L, Haddad D, Li C, Martin A, Gommerman JL), The Journal of Immunology, November 1, 2013